WFD Ventures
10
20M
6
1
0.40
3
- Stages of investment
- Areas of investment
Summary
The main department of described VC is located in the New York. The fund was located in North America if to be more exact in United States.
The high activity for fund was in 2015. The real fund results show that this VC is 9 percentage points less often commits exit comparing to other companies. The higher amount of exits for fund were in 2017. Opposing the other organizations, this WFD Ventures works on 4 percentage points more the average amount of lead investments. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 deals per year.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the WFD Ventures, startups are often financed by New York Angels, F2 Ventures, Blackfin Technology. The meaningful sponsors for the fund in investment in the same round are Avista Capital Partners, General Catalyst, The Entrepreneurs' Fund. In the next rounds fund is usually obtained by Avista Capital Partners, Entrepreneurs Fund, ZGC Shiner Investment.
Among the most successful fund investment fields, there are Software, Biotechnology. The fund has no exact preference in a number of founders of portfolio startups. For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight BionXu2122 Medical Technologies, ProterixBio, ImaCor.
The fund was created by William F. Doyle.
Investments analytics
Analytics
- Total investments
- 10
- Lead investments
- 1
- Exits
- 3
- Follow on index
- 0.40
- Investments by industry
- Biotechnology (8)
- Pharmaceutical (8)
- Health Care (5)
- Medical Device (4)
- Drug Delivery (3) Show 7 more
- Investments by region
-
- Norway (3)
- United States (6)
- Israel (1)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 18
- Group Appearance index
- 0.90
- Avg. company exit year
- 12
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| BionX™ Medical Technologies | 21 Oct 2009 | Biotechnology, Health Care, Pharmaceutical | Early Stage Venture | 20M | United States, Massachusetts |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.